News | December 13, 2010

Women may be Less Likely to Accept Physician’s Heart Treatment Recommendation

December 13, 2010 - One possible explanation for disparities in care for acute coronary syndrome between men and women may be that women are less likely to accept their physician’s recommendation on treatment. The results of the study were reported online today in Annals of Emergency Medicine.

“The well-documented ‘Mars and Venus’ differences between the sexes may play out in how patients make medical decisions,” said lead study author Judd Hollander, M.D., of the department of emergency medicine at the University of Pennsylvania. “Prior studies of coronary patients have attributed disparities in care between men and women to access problems, differences in insurance coverage or physician biases. Our study shows that at least part of the previously noted gender disparity can be explained by patient preferences.”

Researchers enrolled 1,080 patients who came to the emergency department with symptoms of acute coronary syndrome. Women and men both preferred stress testing to cardiac catheterization, and both sexes accepted their physician’s recommendation for stress testing equally (85 percent for both sexes). However, only 65 percent of women stated that they would accept cardiac catheterization, compared to 75 percent of men. And only 67 percent of women said they would accept their physician’s recommendation for angioplasty, versus 73 percent of men. Women were less likely to desire coronary artery bypass grafting than men (61 percent versus 68 percent).

Of patients enrolled in the study who were admitted to the hospital (60 percent of the total), 38 percent of women received diagnostic testing of any kind, versus 45 percent of men. And 10 percent of women received cardiac catheterization, versus 17 percent of men.

Researchers theorized that women might be less willing to undergo diagnostic testing and treatment because they perceive their disease as less severe, or because they have lower tolerance for the risks associated with such procedures.

“The challenge for health care providers is to make sure both men and women have all the information at their disposal to make the best decisions about their own medical care,” Hollander said. “Future studies should focus on identifying the reasons that women appear less likely than men to accept physician-recommended tests and treatments for acute coronary syndrome.”

For more information: www.acep.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init